Who runs this site
PT-141 Doctor is an independent research-summary publisher. It is not a clinic, not a pharmacy, and not a manufacturer. It does not sell any product. It is not affiliated with the developer of bremelanotide, with any compounding pharmacy, or with any vendor. It is an editorial project — a careful reading of the published clinical record on a single compound, written for an adult lay reader who wants a serious starting point.
Why this site exists
Bremelanotide (PT-141) addresses a topic — female sexual desire — that is medically real but socially under-discussed. Many women searching for information feel hesitation about where they land on the internet, and much of what is available is either marketing copy from compounding vendors or fragmentary forum chatter that does not reflect the actual clinical record.
A clear, calmly written summary of the peer-reviewed evidence, the FDA-approved label, and the clinicians who study and prescribe the drug seems like a public good. That is what this site tries to be. It exists to give a reader a clean overview of what is known — and what is not — drawn from the same sources a careful clinician would consult.
Editorial standards
Every quantitative claim on this site — every dose, every effect size, every adverse event rate, every pharmacokinetic value — is keyed to a numbered citation on the references page. The sources are the published peer-reviewed clinical literature (the RECONNECT Phase 3 trials, the 52-week extension, the integrated safety analysis, the mechanism review), the FDA-approved prescribing information for bremelanotide, the LiverTox NIH/NCBI summary, and the 2024 / 2025 international consensus guideline.
Where the literature shows uncertainty — for example, on the question of which downstream neural circuits mediate the desire effect — the uncertainty is described, not hidden. Where investigational programs exist outside the FDA-approved indication (obesity co-administration, PDE5 non-responder studies in men), they are labeled clearly as investigational and not approved.
This site does not editorialize beyond what the evidence supports. It does not recommend any course of action. It does not make claims about off-label use. It does not promote any vendor, pharmacy, or product.
What this site is not
PT-141 Doctor is not a medical practice. It does not provide medical advice, diagnose any condition, or prescribe any medication. Reading this site is not a substitute for evaluation by a qualified clinician — an obstetrician-gynecologist, a primary care physician, or a sexual medicine specialist — who has taken your history in person and can make the clinical judgments that matter.
The site does not sell anything. It does not link to vendors of compounded preparations. It carries no advertising. It is published as editorial commentary on publicly available research and FDA-approved prescribing information.